Some aspects of the influence of formulation on the bioavailability of drugs from solid dosage forms.
D000284:Administration, Oral; D001702:Biopharmaceutics; D002214:Capsules; D003460:Crystallization; D003692:Delayed-Action Preparations; D004077:Digoxin / Q000378:metabolism; D004304:Dosage Forms; D007408:Intestinal Absorption; D010592:Pharmaceutic Aids / Q000009:adverse effects; D012492:Salts / Q000378:metabolism; D012995:Solubility; D013499:Surface Properties; D013607:Tablets; D013810:Therapeutic Equivalency
D002214:Capsules; D003692:Delayed-Action Preparations; D004304:Dosage Forms; D010592:Pharmaceutic Aids; D012492:Salts; D013607:Tablets; D004077:Digoxin